2022
Follicle-stimulating hormone (and luteinizing hormone) in ovarian stimulation: Does the dose matter for cycle success?
Kuokkanen S, Pal L. Follicle-stimulating hormone (and luteinizing hormone) in ovarian stimulation: Does the dose matter for cycle success? Fertility And Sterility 2022, 119: 166-169. PMID: 36529184, DOI: 10.1016/j.fertnstert.2022.12.019.Peer-Reviewed Original ResearchConceptsFollicle-stimulating hormoneOvarian stimulationCycle outcomeDose matterCycle successGonadotropinHormoneWomen
2008
Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization
Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertility And Sterility 2008, 89: 1694-1701. PMID: 18440515, PMCID: PMC2601677, DOI: 10.1016/j.fertnstert.2007.05.055.Peer-Reviewed Original ResearchConceptsNondonor IVF cyclesClinical pregnancyCycle cancellationLive birthsGonadotropin useIVF cyclesSpontaneous miscarriageOvarian reserve statusOvarian hyperstimulation resultsHigh gonadotropinsOvarian stimulationFertilization cyclesIVF outcomesOocyte yieldWorse prognosisRetrospective studyIVF centerImproved outcomesAggressive approachMAIN OUTCOMEPregnancyIVFHigher likelihoodBirthOutcomesSimple Tools for Assessment of Ovarian Reserve (OR): Individual Ovarian Dimensions Are Reliable Predictors of OR
Bowen S, Norian J, Santoro N, Pal L. Simple Tools for Assessment of Ovarian Reserve (OR): Individual Ovarian Dimensions Are Reliable Predictors of OR. Obstetrical & Gynecological Survey 2008, 63: 98-99. DOI: 10.1097/01.ogx.0000300473.00069.0f.Peer-Reviewed Original ResearchSerum FSH levelsFSH levelsFollicle-stimulating hormoneOvarian reserveOvarian dimensionsPremenopausal womenAcademic infertility practicePremenopausal infertile womenProspective observational studyEarly follicular phaseBody mass indexTransvaginal ultrasound measurementCause of infertilityTreatment of infertilityOvarian widthOvarian stimulationIndependent predictorsInfertile womenMass indexSmoking statusInfertility practiceFollicular phaseMale factorOvarian measurementsCommon cause
1998
Malignancy may adversely influence the quality and behaviour of oocytes.
Pal L, Leykin L, Schifren J, Isaacson K, Chang Y, Nikruil N, Chen Z, Toth T. Malignancy may adversely influence the quality and behaviour of oocytes. Human Reproduction 1998, 13: 1837-1840. PMID: 9740435, DOI: 10.1093/humrep/13.7.1837.Peer-Reviewed Original ResearchConceptsMalignant diseaseMalignant disordersAge-matched patientsCell of originTubal infertilityIVF cyclesOvarian stimulationDefinitive treatmentCase seriesCertain malignanciesNeoplastic processPatientsComparable total numberMature oocytesMalignancyFertilization rateDiseasePotential fertilityApparent adverse influenceOocytesPoor qualityDisordersTotal numberAdverse influenceInfertility